TerrAscend Corp Total Assets
TerrAscend Corp total assets. Based on the latest financial reports, TerrAscend Corp (TED) holds total assets worth €557.38 Million EUR (≈ $651.63 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see TED market cap overview for the company's overall valuation and market capitalisation.
Total Assets of TerrAscend Corp (2016–2025)
Total assets of TerrAscend Corp from 2016 to 2025. This chart illustrates how TerrAscend Corp's total assets have evolved over time, based on quarterly financial data. See TerrAscend Corp stock price for real-time trading data and today's change.
TerrAscend Corp - Asset Composition Analysis
TerrAscend Corp Total Assets Breakdown (December 2025)
TerrAscend Corp total assets breakdown as of December 2025. TerrAscend Corp's total assets of €557.38 Million consist of 19.8% current assets and 80.3% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 6.7% |
| Accounts Receivable | €15.14 Million | 2.7% |
| Inventory | €34.05 Million | 6.1% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €167.31 Million | 30.0% |
| Goodwill | €109.77 Million | 19.7% |
Asset Composition Trend (2016–2025)
This chart illustrates how TerrAscend Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore TED current assets to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: TerrAscend Corp's current assets represent 19.8% of total assets in 2025, a decrease from 89.6% in 2016.
- Cash Position: Cash and equivalents constituted 6.7% of total assets in 2025, down from 86.2% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 49.0% of total assets, an increase from 0.0% in 2016.
- Asset Diversification: The largest asset category is intangible assets at 30.0% of total assets.
TerrAscend Corp Competitors by Total Assets
Key competitors of TerrAscend Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
GALDERMA GROUP AG
NYSE:GALDY
|
USA | $13.39 Billion |
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
Germany | €15.41 Trillion |
|
Galderma Group N
SW:GALD
|
Switzerland | CHF12.88 Billion |
|
Enzymatica publ AB
ST:ENZY
|
Sweden | Skr149.24 Million |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
|
China | CN¥13.98 Billion |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
|
China | CN¥17.01 Billion |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518
|
China | CN¥13.68 Billion |
|
Walvax BioTech
SHE:300142
|
China | CN¥10.50 Billion |
TerrAscend Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.38 | 1.94 | 3.03 |
| Quick Ratio | 0.95 | 1.51 | 2.46 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €30.18 Million | €85.84 Million | €206.50 Million |
TerrAscend Corp - Advanced Valuation Insights
This section examines the relationship between TerrAscend Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.45 |
| Latest Market Cap to Assets Ratio | 0.25 |
| Asset Growth Rate (YoY) | -8.2% |
| Total Assets | €557.38 Million |
| Market Capitalization | $140.06 Million USD |
Valuation Analysis
Below Book Valuation: The market values TerrAscend Corp's assets below their book value (0.25x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: TerrAscend Corp's assets decreased by 8.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for TerrAscend Corp (2016–2025)
The table below shows the annual total assets of TerrAscend Corp from 2016 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €557.38 Million ≈ $651.63 Million |
-8.21% |
| 2024-12-31 | €607.23 Million ≈ $709.92 Million |
-8.90% |
| 2023-12-31 | €666.52 Million ≈ $779.23 Million |
-5.00% |
| 2022-12-31 | €701.59 Million ≈ $820.23 Million |
+20.56% |
| 2021-12-31 | €581.93 Million ≈ $680.34 Million |
-3.63% |
| 2020-12-31 | €603.88 Million ≈ $706.00 Million |
+31.06% |
| 2019-12-31 | €460.77 Million ≈ $538.68 Million |
+417.84% |
| 2018-12-31 | €88.98 Million ≈ $104.02 Million |
+28.84% |
| 2017-12-31 | €69.06 Million ≈ $80.74 Million |
+1685.83% |
| 2016-12-31 | €3.87 Million ≈ $4.52 Million |
-- |
About TerrAscend Corp
TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States. The company manufactures vaporizables, concentrates, topicals, flowers, tinctures, and edibles. It offers its products under the brand name Kind Tree Cannabis, Legend, Valhalla Confections, State Flower Cannabis, Ilera Healthcare, Wana, and Cookies. The company also operates retail dispensaries und… Read more